[HTML][HTML] Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review

Y Sakr, M Giovini, M Leone, G Pizzilli, A Kortgen… - Annals of intensive …, 2020 - Springer
Background Preliminary reports have described significant procoagulant events in patients
with coronavirus disease-2019 (COVID-19), including life-threatening pulmonary embolism …

[HTML][HTML] Arginine and endothelial function

J Gambardella, W Khondkar, MB Morelli, X Wang… - Biomedicines, 2020 - mdpi.com
Arginine (L-arginine), is an amino acid involved in a number of biological processes,
including the biosynthesis of proteins, host immune response, urea cycle, and nitric oxide …

[HTML][HTML] The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not?

AO Babalghith, HM Al-Kuraishy, AI Al-Gareeb… - Diagnostics, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) is primarily caused by various forms of severe acute
respiratory syndrome coronavirus type 2 (SARS-CoV-2) variants. COVID-19 is characterized …

[HTML][HTML] SARS-CoV-2 infection in the central and peripheral nervous system-associated morbidities and their potential mechanism

MKM Karuppan, D Devadoss, M Nair, HS Chand… - Molecular …, 2021 - Springer
The recent outbreak of SARS-CoV-2 infections that causes coronavirus-induced disease of
2019 (COVID-19) is the defining and unprecedented global health crisis of our time in both …

[HTML][HTML] The role of acidosis in the pathogenesis of severe forms of COVID-19

YD Nechipurenko, DA Semyonov, IA Lavrinenko… - Biology, 2021 - mdpi.com
Simple Summary Recently, several studies have shown that acidosis, which is increased
acidity in the blood and other body tissues, is often associated with severe COVID-19. In this …

[HTML][HTML] Angiotensin-converting-enzyme 2 and renin-angiotensin system inhibitors in COVID-19: an update

AK Shukla, M Banerjee - High Blood Pressure & Cardiovascular …, 2021 - Springer
Ever since its outbreak, Corona Virus Disease 2019 (COVID-19) caused by SARS-CoV-2
has affected more than 26 million individuals in more than 200 countries. Although the …

Fibrinolysis shutdown in COVID-19: clinical manifestations, molecular mechanisms, and therapeutic implications

JP Meizoso, HB Moore, EE Moore - Journal of the American College of …, 2021 - Elsevier
The COVID-19 pandemic has introduced a global public health threat unparalleled in our
history. The most severe cases are marked by ARDS attributed to microvascular thrombosis …

[HTML][HTML] The B. 1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B. 1 (614G) in Syrian hamsters

T Carroll, D Fox, N van Doremalen, E Ball… - PLoS …, 2022 - journals.plos.org
As novel SARS-CoV-2 variants continue to emerge, it is critical that their potential to cause
severe disease and evade vaccine-induced immunity is rapidly assessed in humans and …

[HTML][HTML] Targeting the SphK-S1P-SIPR pathway as a potential therapeutic approach for COVID-19

EM McGowan, N Haddadi, NT Nassif, Y Lin - International Journal of …, 2020 - mdpi.com
The world is currently experiencing the worst health pandemic since the Spanish flu in 1918—
the COVID-19 pandemic—caused by the coronavirus severe acute respiratory syndrome …

[HTML][HTML] Immuno-thrombotic complications of COVID-19: implications for timing of surgery and anticoagulation

CM Bunch, EE Moore, HB Moore, MD Neal… - Frontiers in …, 2022 - frontiersin.org
Early in the coronavirus disease 2019 (COVID-19) pandemic, global governing bodies
prioritized transmissibility-based precautions and hospital capacity as the foundation for …